Do statins prevent both cardiovascular disease and fracture?

被引：55

作者：

Cummings, SR

Bauer, DC

机构：

[1] Univ Calif San Francisco, Coordinating Ctr, Dept Med, San Francisco, CA 94105 USA

[2] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2000年 / 283卷 / 24期

关键词：

D O I：

10.1001/jama.283.24.3255

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：3255 / 3257

页数：3

共 23 条

[1] An evidence-based assessment of the NCEP Adult Treatment Panel II guidelines [J].

Ansell, BJ ;

Watson, KE ;

Fogelman, AM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (21) :2051-2057

[2]

Bauer DC, 1999, J BONE MINER RES, V14, pS179

[3] Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures [J].

Black, DM ;

Cummings, SR ;

Karpf, DB ;

Cauley, JA ;

Thompson, DE ;

Nevitt, MC ;

Bauer, DC ;

Genant, HK ;

Haskell, WL ;

Marcus, R ;

Ott, SM ;

Torner, JC ;

Quandt, SA ;

Reiss, TF ;

Ensrud, KE .

LANCET, 1996, 348 (9041) :1535-1541

[4] HMG-CoA reductase inhibitors increase BMD in type 2 diabetes mellitus patients [J].

Chung, YS ;

Lee, MD ;

Lee, SK ;

Kim, HM ;

Fitzpatrick, LA .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (03) :1137-1142

[5] Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures - Results from the fracture intervention trial [J].

Cummings, SR ;

Black, DM ;

Thompson, DE ;

Applegate, WB ;

Barrett-Connor, E ;

Musliner, TA ;

Palermo, L ;

Prineas, R ;

Rubin, SM ;

Scott, JC ;

Vogt, T ;

Wallace, R ;

Yates, AJ ;

LaCroix, AZ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (24) :2077-2082

[6] Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene -: Results from a 3-year randomized clinical trial [J].

Ettinger, B ;

Black, DM ;

Mitlak, BH ;

Knickerbocker, RK ;

Nickelsen, T ;

Genant, HK ;

Christiansen, C ;

Delmas, PD ;

Zanchetta, JR ;

Stakkestad, J ;

Glüer, CC ;

Krueger, K ;

Cohen, FJ ;

Eckert, S ;

Ensrud, KE ;

Avioli, LV ;

Lips, P ;

Cummings, SR .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (07) :637-645

[7] Postmenopausal hormone therapy increases risk for venous thromboembolic disease - The heart and estrogen/progestin replacement study [J].

Grady, D ;

Wenger, NK ;

Herrington, D ;

Khan, S ;

Furberg, C ;

Hunninghake, D ;

Vittinghoff, E ;

Hulley, S .

ANNALS OF INTERNAL MEDICINE, 2000, 132 (09) :689-+

[8] HORMONE-THERAPY TO PREVENT DISEASE AND PROLONG LIFE IN POSTMENOPAUSAL WOMEN [J].

GRADY, D ;

RUBIN, SM ;

PETITTI, DB ;

FOX, CS ;

BLACK, D ;

ETTINGER, B ;

ERNSTER, VL ;

CUMMINGS, SR .

ANNALS OF INTERNAL MEDICINE, 1992, 117 (12) :1016-1037

[9]

GRUNDY SM, 1993, JAMA-J AM MED ASSOC, V269, P3015, DOI 10.1001/jama.269.23.3015

[10] Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis - A randomized controlled trial [J].

Harris, ST ;

Watts, NB ;

Genant, HK ;

McKeever, CD ;

Hangartner, T ;

Keller, M ;

Chesnut, CH ;

Brown, J ;

Eriksen, EF ;

Hoseyni, MS ;

Axelrod, DW ;

Miller, PD .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (14) :1344-1352

← 1 2 3 →